Performance Summary - China Railway Construction (01186.HK) reported a revenue of 489.2 billion yuan, a decrease of 5.2% year-on-year, with a net profit of approximately 10.7 billion yuan, down 10.1% [2] - Industrial and Commercial Bank of China (01398.HK) achieved a revenue of 409.1 billion yuan, an increase of 1.8% year-on-year, while net profit fell by 1.4% to 168.1 billion yuan [2] - Agricultural Bank of China (01288.HK) recorded a revenue of 369.79 billion yuan, up 0.7% year-on-year, and a net profit of 139.51 billion yuan, an increase of 2.66% [2] - China Construction Bank (00939.HK) reported a revenue of 385.91 billion yuan, a 3% increase year-on-year, with net profit around 162.08 billion yuan, down 1.4% [2] - Bank of China (03988.HK) had a revenue of 329.42 billion yuan, up 3.61% year-on-year, while net profit decreased by 0.85% to 117.59 billion yuan [2] - Postal Savings Bank of China (01658.HK) reported a revenue of 179.53 billion yuan, a 1.5% increase year-on-year, with net profit of 49.23 billion yuan, up 0.85% [2] - China Merchants Bank (03968.HK) achieved a revenue of 169.92 billion yuan, down 1.7% year-on-year, while net profit increased by 0.3% to 74.93 billion yuan [2] - Bank of Communications (03328.HK) reported a revenue of 133.50 billion yuan, up 0.7% year-on-year, with net profit of 46.02 billion yuan, an increase of 1.6% [2] - Minsheng Bank (01988.HK) had a revenue of 70.70 billion yuan, up 7.8% year-on-year, while net profit decreased by 4.9% to 21.38 billion yuan [2] - China Everbright Bank (06818.HK) reported a revenue of 65.95 billion yuan, down 5.6% year-on-year, with net profit of 24.62 billion yuan, an increase of 0.55% [2] - BYD Company (01211.HK) achieved a revenue of 371.28 billion yuan, up 23.3% year-on-year, with net profit of 15.51 billion yuan, an increase of 13.8% [2] - China Communications Construction Company (01800.HK) reported a revenue of 335.45 billion yuan, down 5.8% year-on-year, with net profit of 9.99 billion yuan, down 16.9% [2] - Lenovo Holdings (03396.HK) achieved a revenue of 281.59 billion yuan, up 21% year-on-year, with net profit of 699 million yuan, an increase of 144% [2] - Great Wall Motors (02333.HK) reported a revenue of 92.34 billion yuan, up 1% year-on-year, with net profit of 6.34 billion yuan, down 10.2% [2] - BYD Electronics (00285.HK) achieved a revenue of 80.61 billion yuan, up 2.6% year-on-year, with net profit of 1.73 billion yuan, an increase of 14% [2] - Country Garden (02007.HK) reported a revenue of 72.57 billion yuan, with a net loss of 19.078 billion yuan [2] - China Reinsurance (01508.HK) achieved a revenue of 61.03 billion yuan, up 0.6% year-on-year, with net profit of 6.244 billion yuan, an increase of 9.03% [2] - Yanzhou Coal Mining Company (01171.HK) reported a revenue of 53.966 billion yuan, down 13.17% year-on-year, with net profit of 4.731 billion yuan, down 38.7% [2] - Jitu Express (01519.HK) achieved a revenue of 5.499 billion USD, up 13.1% year-on-year, with net profit of 156 million USD, an increase of 147.1% [2] - AVIC Industry (02357.HK) reported a revenue of 37.465 billion yuan, up 11.43% year-on-year, with net profit of 1.03 billion yuan, down 17.67% [2] - CITIC Financial Assets (02799.HK) achieved a revenue of 31.136 billion yuan, up 2.9% year-on-year, with net profit of 6.168 billion yuan, an increase of 15.7% [2] - Bank of China Hong Kong (02388.HK) reported a net interest income of 25.06 billion HKD, down 3.5% year-on-year, with net profit of 22.12 billion HKD, an increase of 10.54% [2] - Zoomlion Heavy Industry (01157.HK) achieved a revenue of 24.855 billion yuan, up 1.3% year-on-year, with net profit of 2.765 billion yuan, an increase of 20.84% [2] - New Town Development (01030.HK) reported a revenue of 22.1 billion yuan, down 34.82% year-on-year, with net profit of 895 million yuan, down 32.11% [2] - Huatai Securities (06886.HK) achieved a revenue of approximately 20.98 billion yuan, up 5.86% year-on-year, with net profit of 7.549 billion yuan, an increase of 42.16% [2] - China Sanjiang Chemical (02198.HK) reported a revenue of 9.106 billion yuan, down 1.5% year-on-year, with net profit of 301 million yuan, an increase of 95.5% [2] - Tianjin Bank (01578.HK) achieved a revenue of 8.828 billion yuan, up 0.8% year-on-year, with net profit of 1.988 billion yuan, an increase of 1.1% [2] - Harbin Bank (06138.HK) reported a revenue of 7.386 billion yuan, up 2.6% year-on-year, with net profit of 915 million yuan, an increase of 20% [2] - Qingjian International (01240.HK) achieved a revenue of approximately 4.404 billion HKD, down 9.8% year-on-year, with net profit of 2.992 million HKD, an increase of 25.6% [2] - Xingye Alloy (00505.HK) reported a revenue of 4.389 billion yuan, up 22.1% year-on-year, with net profit of 106 million yuan, down 24.7% [2] - 3SBio (01530.HK) achieved a revenue of 4.355 billion yuan, down 0.8% year-on-year, with net profit of 1.358 billion yuan, an increase of 24.6% [2] - Huya Technology (01860.HK) reported a revenue of 938 million USD, up 47% year-on-year, with adjusted EBITDA of 88.681 million USD, an increase of 41% [2] - Haitong Securities (01905.HK) achieved a revenue of 3.521 billion yuan, down 12.6% year-on-year, with net profit of 785 million yuan, down 3.4% [2] - Dazhong Public Utilities (01635.HK) reported a revenue of approximately 3.449 billion yuan, down 5.8% year-on-year, with net profit of approximately 333 million yuan, an increase of 172.6% [2] Company News - China Biologic Products (01177.HK) received approval for the launch of Zongaitini tablets for the treatment of HER2-mutant non-small cell lung cancer [3] - Shandong High-Speed New Energy (01250.HK) reported a total operating power generation of approximately 3.6744 million MWh, an increase of approximately 6.9% year-on-year [3] - Fosun International (00656.HK) reached a settlement with Cainiao regarding a share buyback involving 350 million USD [3] Buyback Activities - Tencent Holdings (00700.HK) repurchased approximately 55 million HKD worth of shares, buying back 919,000 shares at prices ranging from 594.5 to 605 HKD [3] - China Hongqiao (01378.HK) repurchased approximately 22.7 million HKD worth of shares, buying back 8.9235 million shares at a price of 25.44 HKD [3] - HSBC Holdings (00005.HK) repurchased approximately 15.3 million HKD worth of shares, buying back 1.5276 million shares at prices ranging from 99.8 to 100.7 HKD [3] - Hang Seng Bank (00011.HK) repurchased approximately 2.3517 million HKD worth of shares, buying back 210,000 shares at prices ranging from 111.5 to 112.5 HKD [3] - MGM China (02282.HK) repurchased approximately 1.60602 million HKD worth of shares, buying back 1 million shares at prices ranging from 15.92 to 16.27 HKD [3] - Sinopec Engineering (02386.HK) canceled 136,500 shares that had been repurchased [3]

复星国际(00656)发布公告，增资协议项下载明的所有先决条件均已获满足或获书面豁免，本次增资于 2025年8月29日交割。交割后，公司透过海南矿业（601969）间接持有目标公司15.7895%的股权。 ...

智通财经APP讯，复星国际(00656)发布公告，增资协议项下载明的所有先决条件均已获满足或获书面豁 免，本次增资于2025年8月29日交割。交割后，公司透过海南矿业间接持有目标公司15.7895%的股权。 ...

Core Viewpoint - Fosun International (00656) announced a settlement agreement between its wholly-owned subsidiary, Stater Investment Holdings Limited (SIHL), and Cainiao Smart Logistics Network Limited (Cainiao) regarding the cancellation price of Cainiao shares with Alibaba Group [1] Summary by Relevant Sections - Settlement Agreement Details - The settlement agreement confirms the negotiated cancellation price of USD 0.62 per share for Cainiao shares [1] - The total consideration for all Cainiao shares held by SIHL amounts to USD 350 million [1] - Upon reaching the settlement, all parties must release and waive any claims related to the cancellation price and cannot initiate further legal proceedings regarding the cancellation price [1] - Financial Impact - The settlement will not result in any gains or losses for the group in the fiscal year 2025 [1]

Core Viewpoint - Fosun International (00656.HK) has reached a settlement with Cainiao Smart Logistics Network Co., Ltd. regarding the cancellation price of shares, confirming the cancellation price at USD 0.62 per share for a total consideration of USD 349,792,448.78 for all shares held by Stater Investment Holdings Limited [1] Group 1 - The settlement agreement was signed on August 29, 2025, between Stater Investment Holdings Limited (a wholly-owned subsidiary of Fosun) and Cainiao [1] - The total consideration for the cancellation of all shares held by SIHL amounts to USD 349,792,448.78 [1] - Following the settlement, all parties will release and waive any claims related to the cancellation price and will not initiate any legal proceedings regarding the cancellation price [1] Group 2 - The settlement will not result in any profit or loss for the group in the fiscal year 2025 [1]

Group 1 - The core announcement involves a settlement agreement between Stater Investment Holdings Limited (a wholly-owned subsidiary of Fosun International) and Cainiao Smart Logistics Network Co., Ltd. regarding the cancellation price of Cainiao shares [1] - The cancellation price is set at USD 0.62 per share, with a total consideration of USD 350 million for all Cainiao shares held by SIHL [1] - Following the settlement, all parties will release and waive any claims related to the cancellation price and will not initiate further legal proceedings regarding the cancellation price [1] Group 2 - The settlement will not result in any profit or loss for the group in the fiscal year 2025 [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準 確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產 生或因倚賴該等內容而引致的任何損失承擔任何責任。 有關完成增資豐瑞氟業 茲提 述 復星 國 際有 限公 司 （「本公司 」） 於 2025 年 8 月 17 日 刊 發之 公 告（「 該 公 告 」），內容有關 海南礦業簽訂增資協議 以增資豐瑞氟業 。除文義另有所指 外，本公告所界定的詞彙與該等公告所使用者具有相同涵義。 董事會欣然宣佈， 增資協議項 下 載明的所有先決條件 均 已獲滿足或 獲 書面豁 免，本次增資於 2025 年 8 月 29 日交割。 交 割後 ， 本公司透過海南礦業間接 持有目標公司 15.7895%的股權。 承董事會命 最新進展公告 須予披露交易 董事長 郭廣昌 2025 年 8 月 29 日 於本公告日期，本公司之執行董事為郭廣昌先生、汪群斌先生、陳啟宇先生、徐曉亮先生、 龔平先生、黃震先生及潘東輝先生；非執行董事為李樹培先生、李富華先生及羅元澧先生； 而獨立非執行董事為章晟曼先生、張化橋先生、張彤先生、李開復博士及曾璟璇女士 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準 確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產 生或因倚賴該等內容而引致的任何損失承擔任何責任。 自願公告 關於菜鳥智慧物流網絡有限公司之 爭議解決 本公告乃復星國際有限公司（「 本公司 」，連同其附屬公司統稱「本集團 」） 自願刊發。 本公司股東及潛在投資者於買賣本公司之證券時務請審慎行事。 茲提述本公司 分別於 2025 年 3 月 28 日及 2025 年 3 月 30 日刊發之盈利警告 公告（「盈利警告公告 」）及截至 2024 年 12 月 31 日止年度 之 業績公告， 以 及 於 2025 年 4 月 25 日刊發之 本公司 年報。除文義另有所指外，本公告所使用 之詞彙與盈利警告公告所界定者具有相同涵義。 本公司 董事 會 （「董事會 」）謹 此 通知 本 公司 之 股東 及 潛在 投資 者 ，於 2025 年 8 月 29 日 ，Stater Investment Holdings Limited（「SIHL」）（ 本公 司 之全 資 附屬 公 司 ） 與 菜 鳥 智 慧 物 流 網 ...

Core Viewpoint - Fosun International's Chairman Guo Guangchang emphasized the company's commitment to increasing investments in the biopharmaceutical sector, aiming to deepen its focus on advantageous industries and capture global market leadership [1]. Group 1: Business Performance - In the first half of the year, Fosun achieved significant breakthroughs across multiple business segments, particularly in the biopharmaceutical sector [1]. - The company is poised to leverage growth opportunities through technological innovation to achieve breakthrough advancements [1]. Group 2: Innovation Drug Development - Fosun has a pipeline of innovative drug candidates with a potential global market size ranging from $5 billion to $10 billion [1]. - In addition to its subsidiary, Fuhong Hanlin, Fosun is advancing its CAR-T technology platform and other innovative drug developments, which present substantial growth potential [1]. Group 3: Strategic Approach - Guo highlighted the importance of both licensing in and licensing out for innovative drugs, indicating a strategic approach to not rush into licensing agreements, even if they may yield high prices [1]. - The company aims to build its global capabilities in research and development, clinical trials, and sales within the biopharmaceutical field, which is seen as a fundamental pathway for Fosun to evolve into a global pharmaceutical giant [1].

Core Viewpoint - Fosun International is committed to increasing investments in the biopharmaceutical sector, focusing on leveraging its strengths to capture global market opportunities [1] Group 1: Business Strategy - Fosun has achieved significant breakthroughs in multiple business segments in the first half of the year, particularly in the biopharmaceutical sector, and aims to drive growth through technological innovation [1] - The company has a pipeline of innovative drugs with a potential global market size of $5 billion to $10 billion, including products from its subsidiaries such as Fosun Pharma and its CAR-T technology platform [1][2] Group 2: Innovation and R&D - Fosun emphasizes the importance of both licensing in and licensing out for innovative drugs, aiming to develop products into globally competitive offerings rather than rushing to license them out [2] - The company believes that cancer treatment will not rely on a single method but will involve a combination of drugs, devices, and multi-molecular therapies, positioning itself uniquely in this area [2] Group 3: Long-term Vision - Fosun's leadership highlights that building a competitive enterprise requires a long-term commitment, as seen in the 15-year journey of its subsidiary, Fosun Pharma, which has seen substantial investment with delayed returns [3] - The company intends to focus on its established industries, innovating within traditional sectors, such as the recent development of a new low-alcohol product in the liquor industry to cater to health-conscious consumers [3]